000 01306 a2200349 4500
005 20250514003451.0
264 0 _c20011018
008 200110s 0 0 eng d
022 _a0166-0934
024 7 _a10.1016/s0166-0934(01)00335-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJen, C M
245 0 0 _aLimitations and improvements of the quantiplex branched-DNA assay in Hepatitis B virus-infected patients receiving lamivudine.
_h[electronic resource]
260 _bJournal of virological methods
_cAug 2001
300 _a203-10 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aBranched DNA Signal Amplification Assay
_xmethods
650 0 4 _aDNA, Viral
_xblood
650 0 4 _aHepatitis B
_xdiagnosis
650 0 4 _aHepatitis B virus
_xgenetics
650 0 4 _aHumans
650 0 4 _aLamivudine
_xtherapeutic use
650 0 4 _aReproducibility of Results
650 0 4 _aReverse Transcriptase Inhibitors
_xtherapeutic use
650 0 4 _aSensitivity and Specificity
700 1 _aYoung, K C
700 1 _aCheng, P N
700 1 _aKao, A W
700 1 _aChang, T T
773 0 _tJournal of virological methods
_gvol. 96
_gno. 2
_gp. 203-10
856 4 0 _uhttps://doi.org/10.1016/s0166-0934(01)00335-4
_zAvailable from publisher's website
999 _c11373918
_d11373918